Stay updated on CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Sign up to get notified when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.

Latest updates to the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Locations section was updated to include new site locations across multiple US states, Canada (Ontario and Quebec), and Western Australia, with a revision from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check22 days agoChange DetectedThe page now shows 'Last Update Posted (Estimated)' instead of 'Last Update Posted', changing how the update timestamp is presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedUpdates to the study record history include new dates (2025-12-05 and 2025-12-01) and removal of older entries (2024-10-28 and 2024-10-25), with no changes to core content such as eligibility, interventions, or contacts. (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.1%

- Check36 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed; this is a minor administrative update that does not affect the study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedThe general operating-status notice about government funding has been removed. The trial details and page navigation remain unchanged.SummaryDifference0.1%

Stay in the know with updates to CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.